• Kang Hee Cheol and related parties increased their GFC Life Science shareholding to 37.66% from 37.64%, as of October 23, 2026.
• The CEO bought 744 voting shares on the market during October 19–21.
• Combined holdings reached 2,005,373 shares and related instruments; their voting-share stake rose to 36.89% from 36.88%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GFC Life Science Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261023000321), on October 23, 2026, and is solely responsible for the information contained therein.